Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Kala Bio Inc. chart...

About the Company

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala’s website at www.kalarx.com.

CEO

Mark Iwicki

Exchange

NASDAQ

Website

http://kalarx.com/

$9M

Total Revenue

111

Employees

$21M

Market Capitalization

-0.17

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $KALA News

KALA BIO (KALA) Reports Q3 Loss, Misses Revenue Estimates

4mon ago, source: Hosted on MSN

KALA BIO (KALA) came out with a quarterly loss of ... Syros Pharmaceuticals, Inc. (SYRS), another stock in the same industry, has yet to report results for the quarter ended September 2023.

KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference

22d ago, source: Yahoo Finance

About KALA BIO, Inc. KALA is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye.

KALA BIO, Inc. Common Stock (KALA)

6y ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

KALA BIO, Inc. (KALA) Stock Historical Prices & Data - Yahoo Finance

1mon ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Kala Bio Inc

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Kala Bio Inc KALA

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

KALA BIO Inc.

1y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...